Osteoporosis or fracture risk associated with thiazolidinedione and proton pump inhibitor co-administration in patients with type 2 diabetes mellitus

Ock, M; Lee, S; Kim, H

Kim, H (通讯作者),Sookmyung Womens Univ, Coll Pharm, Cheongpa Ro 47 Gil 100, Seoul 04310, South Korea.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022; 47 (7): 1028

Abstract

What is known and objective Thiazolidinedione (TZD) and proton pump inhibitor (PPI) belong to classes of drugs that affect bone metabolism; however, f......

Full Text Link